[
  {
    "date": "2023-12-30",
    "symbol": "BICX",
    "period": "FY",
    "entityregistrantname": "BioCorRx Inc.",
    "entitycentralindexkey": 1443863,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "2023-12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityfilenumber": "000-54208",
    "entityincorporationstatecountrycode": "NV",
    "entitytaxidentificationnumber": "90-0967447",
    "entityaddressaddressline1": "2390 East Orangewood Avenue",
    "entityaddressaddressline2": "Suite 500",
    "entityaddresscityortown": "Anaheim",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92806,
    "cityareacode": 714,
    "icfrauditorattestationflag": "false",
    "auditorname": "Marcum LLP",
    "auditorlocation": "Marlton, New Jersey",
    "auditorfirmid": 688,
    "localphonenumber": "462-4880",
    "entityinteractivedatacurrent": "Yes",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 65222,
    "accountsreceivablenetcurrent": 740,
    "grantsreceivable": 76266,
    "prepaidexpensecurrent": 44891,
    "assetscurrent": 187119,
    "propertyplantandequipmentnet": 50943,
    "operatingleaserightofuseasset": 97278,
    "finitelivedintangibleassetsnet": 9027,
    "depositassets": 44520,
    "otherassets": 53547,
    "assets": 388887,
    "accountspayableandaccruedliabilitiescurrent": 4649179,
    "operatingleaseliabilitycurrent": 122732,
    "derivativeliabilities": 53460,
    "notespayablecurrent": 606750,
    "notespayablecurrentandnoncurrent": 999088,
    "liabilitiescurrent": 6431209,
    "economicinjurydisasterloanlongterm": 72466,
    "contractualobligation": 3822746,
    "operatingleaseliabilitynoncurrent": 10945,
    "deferredrevenuenoncurrent": 4045,
    "liabilities": 10341411,
    "preferredstockvalue": 16000,
    "commonstockvalue": 8674,
    "commonstocksharessubscriptions": 100009,
    "additionalpaidincapital": 68149029,
    "retainedearningsaccumulateddeficit": -78103018,
    "stockholdersequity": -9823690,
    "minorityinterest": -128834,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": -9952524,
    "liabilitiesandstockholdersequity": 388887,
    "duetorelatedparty": 1683453,
    "debtdiscountonnotespayable": 354730,
    "debtdiscountrelatedparties": 77295,
    "discountonroyaltyobligationrelatedparties": 4899354,
    "preferredstocksharesauthorized": 600000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 750000000,
    "commonstocksharesissued": 8674029,
    "commonstocksharesoutstanding": 8674029,
    "preferredstocksharesdesignated": 80000,
    "preferredstocksharesissued": 80000,
    "preferredstocksharesoutstanding": 80000,
    "revenues": 89160,
    "costofrevenue": 35986,
    "researchanddevelopmentexpense": 891063,
    "sellinggeneralandadministrativeexpense": 2875119,
    "impairmentofintangibleassetsfinitelived": 47980,
    "depreciationandamortization": 26808,
    "operatingexpenses": 3876956,
    "operatingincomeloss": -3787796,
    "interestexpenserelatedpartytransactions": 692586,
    "interestexpense": 2786,
    "gainslossesonextinguishmentofdebt": -34338,
    "grantincome": 932996,
    "othernonoperatingincome": 5275,
    "nonoperatingincomeexpense": 17306,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -3770490,
    "netincomeloss": -3770490,
    "noninterestincome": 3577,
    "incomelossattributabletoparent": -3766913,
    "earningspersharesbasicanddiluted": -0.45,
    "weightedaveragenumberofsharesoutstandingbasicanddiluted": 8344079,
    "sharesissued": 80000,
    "commonstockissuedinconnectionwithsubscriptionagreementshares": 518801,
    "commonstockissuedinconnectionwithsubscriptionagreementamount": 519,
    "commonstockissuedforservicesrenderedshares": 140701,
    "commonstockissuedforservicesrenderedamount": 140,
    "commonstockissuedinconnectionwithconversionofpromissorynotesandaccountspayableshares": 207606,
    "commonstockissuedinconnectionwithconversionofpromissorynotesandaccountspayableamount": 208,
    "commonstockissuedinconnectionwithissuanceofpromissorynotesshares": 88285,
    "commonstockissuedinconnectionwithissuanceofpromissorynotesamount": 88,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": 50620,
    "warrantsissuedinconnectionwithissuanceofpromissorynotes": 373127,
    "profitloss": -3770490,
    "amortizationofdiscountonroyaltyobligation": 477436,
    "amortizationofdebtdiscountpremium": 166198,
    "operatingleaserightofuseassetamortizationexpense": 173128,
    "sharebasedcompensation": 277055,
    "increasedecreaseinaccountsreceivable": -34638,
    "increasedecreaseingrantreceivable": -53886,
    "increasedecreaseinprepaidexpense": -37874,
    "increasedecreaseinaccountspayableandaccruedliabilities": 803117,
    "increasedecreaseinoperatingleaseliability": -181994,
    "increasedecreaseindeferredrevenue": -33256,
    "netcashprovidedbyusedinoperatingactivities": -1853282,
    "proceedsfromcommonstocksubscriptionandroyaltyagreement": 915000,
    "paymenttoeconomicinjurydisasterloan": 1384,
    "repaymentsofrelatedpartydebt": 35000,
    "proceedsfromnotespayable": 600000,
    "proceedsfromrelatedpartydebt": 371273,
    "netcashprovidedbyusedinfinancingactivities": 1849889,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -3393,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 65222,
    "interestpaidnet": 17188,
    "commonstockissuedinconnectionwithissuanceofpromissorynote": 92623,
    "commonstockissuedinconnectionwithconversionofpromissorynotesandaccountspayable": 361892,
    "derivativeliabilityrecognizedinconnectionwithissuanceofpromissorynotes": 53460,
    "commonstockissuedinconnectionwithissuanceofpromissorynotes": 373127,
    "salescommissionsandfees": 20852,
    "projectsupportincome": 25817,
    "investmentcompanydividenddistribution": 33256,
    "membershipprogramfees": 9235,
    "deferredrevenueshortterm": 4045,
    "deferredrevenue": 4045,
    "derivativeliabilityfairvaluegrossasset": 53460,
    "sharesunderlyingoptionsoutstanding": 891443,
    "sharesunderlyingwarrantsoutstanding": 1565856,
    "convertiblepreferredstockoutstanding": 240000,
    "weightedaveragenumberofdilutedsharesoutstanding": 2697299,
    "advertisingexpense": 113170,
    "impairmentlosssoftwaredevelopmentcosts": 47980,
    "grantreceivables": 76266,
    "grantfundingindirectcost": 516218,
    "variableinterestentityownershippercentage": 0.5,
    "royaltyobligationsdescription": "The Company accounted for royalty obligations as debt in accordance with ASC 470-10-25 and derived a debt discount, which is amortized using the straight line method over the expected life of the arrangement, which is 15 years. The Company has no obligation to repay the then outstanding balance if during the expected life of 15 years the treatment is discontinued",
    "descriptionofnoncontrollinginterest": "Due to a management fee equal to 65% of the Medical Corporation’s gross collected monthly revenue, 65% of the Medical Corporation’s earnings was allocated to the Company, and 35% to the non-controlling interest. Due to the Company’s retaining 75.8% ownership of BioCorRx Pharmaceuticals, Inc., 75.8% of BioCorRx Pharmaceuticals, Inc.’s earnings was allocated to the Company, and 24.2% to the non-controlling interest",
    "royaltyexpense": 7171200,
    "propertyplantsandequipmentusefullife": "P5Y",
    "workingcapitaldeficiency": -6244090,
    "promissorynotepayable": 150000,
    "exchangeagreementdescription": "total proceeds has a stated interest rate of 8% per annum and due within one year. $221,273 of the total proceeds bears no interest and due on demand",
    "fundingdescription": "The grant provides for (i) $4,131,123 in funding during the first year, (ii) $3,638,268 during the second-year, and (iii) $3,260,586 during the third-year subject to the terms and conditions specified in the grant",
    "awardedagrant": 11029977,
    "notesissued1": 600000,
    "notespayableinterestrate": 0.08,
    "stockissuedduringperiodsharesnewissues": 518801,
    "stockissuedduringperiodsharesother": 171296,
    "grossproceeds": 915000,
    "shareprice": 1.6,
    "gainlossrelatedtolitigationsettlement": 34338,
    "prepaidinsurance": 18511,
    "prepaidsubscriptionservices": 26380,
    "propertyplantandequipmentgross": 45519,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 143608,
    "depreciation": 25629,
    "totalleaseliability": 133677,
    "operatingleaseliability": 10945,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 129012,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 11018,
    "presentvaluediscount": -6353,
    "leaseliability": 133677,
    "operatingleaseexpense": 138932,
    "operatingleasesrentexpensenet": 138932,
    "acquiredfinitelivedintangibleassetsweightedaverageusefullife": "P1Y",
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 500333,
    "totalleaseexpense": 147798,
    "descriptionoflesseeleasingarrangementscapitalleases": "On October 25, 2023, the Company terminated the lease and reversed the right to use assets and lease liability",
    "leaseandrentalexpense": 9905,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1169,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1169,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1169,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1169,
    "finitelivedintangibleassetsamortizationexpenserollingafteryearfive": 4351,
    "totalfutureamortizationofthepatents": 9027,
    "amortizationofintangibleassets": 1179,
    "accumulatedamortization": 6173,
    "accountspayablecurrent": 2473457,
    "interestanddividendspayablecurrent": 1268264,
    "interestpayableonnotespayablerelatedparties": 478920,
    "accrualoflossoncontingency": 322000,
    "interestpayableoneidlloan": 5675,
    "accruedexpenses": 57542,
    "accruedreclamationcostscurrent": 43321,
    "advancesfromathirdparty": 21480,
    "othernotespayable": 100000,
    "othernotespayablepromissory": 49605,
    "othernotespayablespromissory": 69104,
    "othersnotespayablespromissory": 84015,
    "othersnotespayablespromissoryother": 82546,
    "notespayable": 500000,
    "interestanddebtexpense": 23878,
    "advancesfromrelatedpartiescurrent": 1500,
    "duetorelatedpartiesnoncurrents": 663610,
    "interestexpensesrelatedparty": 692586,
    "adjustmentforamortization": 477436,
    "proceedsfromunsecurednotepayables": 171273,
    "outstandingbalance": 20000,
    "debtinstrumentincreaseaccruedinterest": 57412,
    "accumulatedinterestnotespayable": 478920,
    "duefromrelatedparty": 1500,
    "outstandingprincipalbalanceonissuanceofpromissorynote": 163610,
    "warrantissue": 119617,
    "capitalleasesfutureminimumpaymentsreceivabledueinrollingyearthree": 16,
    "capitalleasesfutureminimumpaymentsreceivabledueinrollingyearfour": 1598,
    "capitalleasesfutureminimumpaymentsreceivabledueinrollingyearfive": 1651,
    "capitalleasesfutureminimumpaymentsreceivabledueinrollingafteryearfive": 69201,
    "capitalleasesfutureminimumpaymentsreceivable": 72466,
    "accumulatedinterestoneidlloan": 5675,
    "proceedfromsba": 5000,
    "descriptionofprincipalandinterestpayble": "the balance of principal and interest will be payable over thirty (30) years from the date of the promissory note",
    "proceedsfromloanoriginations1": 74300,
    "shorttermdebtinterestrateincrease": 0.0375,
    "interestpaid": 2971,
    "installmentpayments": 363,
    "advancesfromsba": 5000,
    "othernoncashexpense": 7171200,
    "expectedlifeofarrangement": "P15Y",
    "promissorynotesaggregatevalue": 600000,
    "proceedsfromcustomers": 300000,
    "stockissuedduringperiodsharesissuedforservices": 140701,
    "renderedvalue": 226435,
    "stockissuedduringperiodvalueissuedforservices": 88949,
    "conversionofstocksharesissued1": 50845,
    "earningspersharebasic": 1.75,
    "sharebasedgoodsandnonemployeeservicestransactionsvaluationmethodriskfreeinterestrate": 0.036,
    "sharebasedgoodsandnonemployeeservicestransactionvaluationsmethodriskfreeinterestrate": 0.036,
    "sharebasedgoodsandnonemployeeservicestransactionsvaluationmethodexpectedterm1": "P5Y",
    "sharebasedgoodsandnonemployeeservicestransactionsvaluationmethodexpectedvolatilityrate": 1.5062,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 891443,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 8334,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 145000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 889151,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.41,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 3,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.41,
    "outstandingbeginning": "P3Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentgrantinperiod": "P4Y6M",
    "outstandingatending": "P3Y",
    "exercisableatendofyear": "P3Y",
    "weightedaverageremaininglifeinyears": "P2Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 392802,
    "warrantexercisepriceincrease": 3.31,
    "saleofstockpricepershare": 0.78,
    "allocatedsharebasedcompensationexpense": 63941,
    "stockcompensationexpenseunamortized": 3796,
    "weightedaverageremaininglife": "P5M",
    "purchaseofcommonstockshares": 532001,
    "temporaryequityaggregateamountofredemptionrequirement": 420055,
    "stockoptionexercisepriceincrease": 2,
    "planterminationtermperiod": "P3M",
    "optiongrantable": 145879,
    "percentofissuedandoutstandingshares": 0.2,
    "proceedsfromstockoptionsexercised": 41145,
    "notespayablesrelatedpartiescurrentandnoncurrent": 1683453,
    "stocknotissued": 4687,
    "concentrationriskpercentage": 0.66,
    "accountsreceivablenet": 740,
    "netincomelossusedforcalculatingminorityinterest": -7384,
    "averagenoncontrollinginterestpercentageofprofitlosses": 0.242,
    "netlossattributabletothenoncontrollinginterest": -1787,
    "noncontrollinginterestbeginningbalance": -125257,
    "noncontrollinginterestendingbalance": -128834,
    "shareissuetoconsultant": 3000,
    "reductionsinotherassetsamount": 1417,
    "considerationamount": 503089,
    "attorneysfees": 235886,
    "attorneysfeesreceived": 332503,
    "recognizedgainlossoncontingency": -322000,
    "receivecommonstockequivalent": 5000,
    "othercommitment": 28936,
    "royaltydue": 91,
    "businesscombinationcontingentconsiderationliability": 1531926,
    "paidtoalpinecreek": 1620000,
    "payablecommitmentdescription": "On any other proprietary implant distribution, that excludes the “treatment”, for alcohol and opioid addiction and for which no other payment is due, the Company shall pay 2.5% of the Company’s gross profit for implant distribution not to exceed $100 per sale. On or about January 1, 2021, Mr. Galligan acquired from Alpine Creek the rights to the royalty agreement by and between the Company and Alpine Creek. As of December 31, 2023 and 2022, there are no payments due",
    "debtconversionconvertedinstrumentsharesissued1": 2227575,
    "issuanceprice": 2,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0589,
    "otherincreasedecrease": -0.0081,
    "interestaddback": -0.0228,
    "effectiveincometaxratereconciliationtaxcreditsother": -0.002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.236,
    "stockoptionsissuedforservices": 2077903,
    "deferredtaxassetsoperatinglosscarryforwards": 7969941,
    "capitalizationundersectionact": 510302,
    "accrualtocash": 684411,
    "deferredtaxassetsother": 185316,
    "deferredtaxassetsgross": 11427873,
    "royaltyobligation": -172730,
    "righttouseassets": -27222,
    "deferredincometaxliabilities": 199952,
    "deferredtaxassetsliabilitiesnet": 11227921,
    "deferredtaxassetsvaluationallowance": 11227921,
    "operatinglosscarryforwards": 13700000,
    "cumulativechangeinownership": 0.5,
    "federalnetoperatinglossescarryforwarddescription": "the Company had federal net operating loss carryforwards of approximately $23.0 million, of which $9.3 million, if not utilized, expire beginning by 2029"
  },
  {
    "date": "2022-12-30",
    "symbol": "BICX",
    "period": "FY",
    "entityregistrantname": "BioCorRx Inc.",
    "entitycentralindexkey": 1443863,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "December 31, 2022",
    "entityfilercategory": "Non-accelerated filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "000-54208",
    "entityincorporationstatecountrycode": "Nevada",
    "entitytaxidentificationnumber": "90-0967447",
    "entityaddressaddressline1": "2390 East Orangewood Avenue",
    "entityaddressaddressline2": "Suite 500",
    "entityaddresscityortown": "Anaheim",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92806,
    "cityareacode": 714,
    "auditorname": "Friedman LLP",
    "auditorlocation": "Marlton, New Jersey",
    "auditorfirmid": 688,
    "localphonenumber": "462-4880",
    "entityinteractivedatacurrent": "Yes",
    "cash": 68615,
    "accountsreceivablenet": 35378,
    "grantsreceivable": 130152,
    "prepaidexpensecurrent": 82765,
    "assetscurrent": 316910,
    "propertyplantandequipmentnet": 76572,
    "operatingleaserightofuseasset": 270406,
    "finitelivedintangibleassetsnet": 10206,
    "capitalizedsoftwaredevelopmentcostsforsoftwaresoldtocustomers": 47980,
    "longterminvestments": 44520,
    "otherassets": 102706,
    "assets": 766594,
    "accountspayableandaccruedliabilitiescurrent": "null",
    "deferredrevenuecurrent": 33256,
    "operatingleaseliabilitycurrent": 134343,
    "notespayablecurrent": 297602,
    "notespayablerelatedpartiesclassifiedcurrent": 990637,
    "liabilitiescurrent": "null",
    "otherloanspayablelongterm": 73850,
    "contractualobligation": "null",
    "operatingleaseliabilitynoncurrent": 181328,
    "deferredrevenuenoncurrent": 4045,
    "liabilities": "null",
    "preferredstockvalue": 5616,
    "commonstockvalue": 136290,
    "commonstocksharessubscriptions": 100000,
    "additionalpaidincapital": "null",
    "retainedearningsaccumulateddeficit": "-null",
    "totaldeficitattributabletobiocorrxinc": "-null",
    "minorityinterest": -125257,
    "stockholdersequity": -125257,
    "liabilitiesandstockholdersequity": 766594,
    "duetorelatedpartiesnoncurrent": 250527,
    "accountspayablerelatedpartiescurrent": "null",
    "debtdiscountonnotespayable": 23878,
    "debtdiscountonnotespayablerelatedparties": 49473,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": 7718636,
    "preferredstocksharesauthorized": 600000,
    "preferredstocksharesdesignated": 160000,
    "preferredstocksharesissued": 160000,
    "preferredstocksharesoutstanding": 80000,
    "revenues": 213841,
    "costofimplantsandothercosts": 15279,
    "researchanddevelopmentexpense": "null",
    "sellinggeneralandadministrativeexpense": "null",
    "depreciationandamortization": 27450,
    "operatingexpenses": "null",
    "operatingincomeloss": "-null",
    "interestexpenserelatedparty": 2786,
    "interestexpense": 9927,
    "lossonsettlementofdebt": 198939,
    "losscontingencylossinperiod": 322000,
    "grantincome": "null",
    "otherincome": 139381,
    "othernonoperatingincomeexpense": 321163,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": "-null",
    "netincomeloss": -7419,
    "noninterestincome": 7419,
    "incomelossattributabletoparent": "-null",
    "netlosspercommonsharebasicanddiluted": -0.61,
    "weightedaveragenumberofcommonsharesoutstandingbasicanddiluted": "null",
    "sharesissued": "null",
    "commonstockissuedinconnectionwithsubscriptionagreementshares": 340505,
    "commonstockissuedinconnectionwithsubscriptionagreementamount": "null",
    "stockissuedduringperiodsharesissuedforservices": 111443,
    "stockissuedduringperiodvalueissuedforservices": 100000,
    "stockgrantedduringperiodvaluesharebasedcompensation": 92973,
    "warrantsissuedinconnectionwithloandefault": 86821,
    "warrantsissuedinconnectionwithloandefaultrelatedparty": 214975,
    "commonstockissuedinconnectionwithconversionofpromissorynotesandaccountspayableshares": 485220,
    "commonstockissuedinconnectionwithconversionofpromissorynotesandaccountspayableamount": "null",
    "commonstockissuedinconnectionwithissuanceofpromissorynotesshares": 82500,
    "commonstockissuedinconnectionwithissuanceofpromissorynotesamount": 167640,
    "profitloss": "null",
    "depreciationdepletionandamortization": 27450,
    "amortizationofdiscountonroyaltyobligation": 477436,
    "amortizationofdebtdiscountpremium": 17399,
    "operatingleaserightofuseassetamortizationexpense": 114515,
    "sharebasedcompensation": 354509,
    "gainslossesonextinguishmentofdebt": 133424,
    "noncashinterestfordebtdiscount": 378686,
    "increasedecreaseinaccountsreceivable": 33878,
    "increasedecreaseinotherreceivables": -73793,
    "increasedecreaseinprepaidexpense": 1864,
    "increasedecreaseinaccountspayableandaccruedliabilities": 838071,
    "increasedecreaseinoperatingleaseliability": -119734,
    "increasedecreaseindeferredrevenue": -34981,
    "netcashprovidedbyusedinoperatingactivities": "-null",
    "proceedsfromissuanceofcommonstock": "null",
    "paymenttoeconomicinjurydisasterloan": 450,
    "proceedsfromnotespayable": 100000,
    "proceedsfromrelatedpartydebt": 675000,
    "netcashprovidedbyusedinfinancingactivities": "null",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -17223,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 68615,
    "interestpaidnet": 3750,
    "commonstockissuedinconnectionwithissuanceofpromissorynotes": 167641,
    "commonstockissuedinconnectionwithconversionofpromissorynotesandaccountspayable": "null",
    "salescommissionsandfees": 14360,
    "projectsupportincome": 150578,
    "investmentcompanydividenddistribution": 37293,
    "membershipprogramfees": 11610,
    "deferredrevenueshortterm": 33256,
    "deferredrevenuelongterm": 4045,
    "deferredrevenue": 37301,
    "sharesunderlyingoptionsoutstanding": 874058,
    "sharesunderlyingwarrantsoutstanding": 333855,
    "convertiblepreferredstockoutstanding": 240000,
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "collateralizedfinancings": 47980,
    "advertisingexpense": 325965,
    "grantreceivables": 122652,
    "directtotelevisionfilmcostsdevelopment": 253208,
    "grantfundingindirectcost": 516218,
    "allocationofremainingfaindirectcost": 9671,
    "variableinterestentityownershippercentage": 0.15,
    "royaltyobligationsdescription": "The Company accounted for royalty obligations as debt in accordance with ASC 470-10-25 and derived a debt discount, which is amortized using the straight line method over the expected life of the arrangement, which is 15 years",
    "royaltyexpense": "null",
    "propertyplantandequipmentusefullife": 15,
    "workingcapitaldeficiency": "-null",
    "advancereceived": 75000,
    "dueamount": 75000,
    "exchangeagreementdescription": "the Company entered into an Exchange Agreement (the “Joseph Exchange Agreement”) with Joseph J Galligan, a member of the Company’s Board, pursuant to which Mr. Joseph Galligan agreed to exchange of the promissory note then outstanding of $125,000, the accrued interest on the promissory note of $46,548, and the unpaid service fees of $175,090 into the Company’s 194,740 shares of common stock",
    "notesissued1": 600000,
    "notespayableinterestrate": 0.05,
    "stockissuedduringperiodsharesother": 110619,
    "grossproceeds": "null",
    "prepaidinsurance": 4284,
    "prepaidsubscriptionservices": 49901,
    "prepaidresearchanddevelopment": 7480,
    "otherprepaidexpensecurrent": 21100,
    "propertyplantandequipmentgross": 194551,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 117979,
    "totalleaseliability": 315671,
    "operatingleaseliability": 181328,
    "lesseeoperatingleaseliabilitypaymentsdue": 154771,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 159420,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 31690,
    "presentvaluediscount": -30210,
    "leaseliability": 315671,
    "operatingleaseexpense": 144978,
    "operatingleasesrentexpensenet": 144978,
    "totalleaseexpense": 150196,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1169,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1169,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1169,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1169,
    "finitelivedintangibleassetsamortizationexpenserollingafteryearfive": 5530,
    "totalfutureamortizationofthepatents": 10206,
    "amortizationofintangibleassets": 1179,
    "finitelivedintangibleassetusefullife": 5,
    "accumulatedamortization": 4994,
    "goodwillimpairmentloss": 141480,
    "accountspayablecurrent": "null",
    "interestanddividendspayablecurrent": "null",
    "interestpayableonnotespayablerelatedparties": 332567,
    "accrualoflossoncontingency": 322000,
    "interestpayableoneidlloan": 5860,
    "accruedexpenses": 27524,
    "advancesfromathirdparty": 21480,
    "promissorynotepayable": 200000,
    "othernotespayable": 76122,
    "notespayable": 55000,
    "fairvalueadjustmentofwarrants": 214975,
    "notespayablerelatedpartiesnoncurrent": 75000,
    "outstandingpromissorynote": 300000,
    "proceedsfromunsecurednotepayables": 20000,
    "amortizationofadvanceroyalty": 477436,
    "outstandingbalance": 20000,
    "accumulatedinterestnotespayable": 332567,
    "warrantissue": 119617,
    "duefromrelatedparties": 1500,
    "outstandingprincipalbalanceonissuanceofpromissorynote": 163610,
    "interestexpenseother": 1000,
    "proceedsfromloanoriginations1": 74300,
    "capitalleasefutureminimumpaymentsreceivabledueinrollingyearfour": 16,
    "capitalleasefutureminimumpaymentsreceivabledueinrollingyearfive": 1598,
    "capitalleasefutureminimumpaymentsreceivabledueinrollingafteryearfive": 72236,
    "capitalleasefutureminimumpaymentsreceivable": 73850,
    "accumulatedinterestoneidlloan": 5860,
    "advancesfromsba": 5000,
    "balanceofprincipalandinterestpayableperioddescription": "the balance of principal and interest will be payable over thirty (30) years from the date of the promissory note",
    "shorttermdebtinterestrateincrease": 0.1,
    "paymentsofprincipal": 450,
    "paymentsofinterest": 1003,
    "monthlypaymentsofprincipalandinterest": 363,
    "adjustmentforamortization": 477436,
    "othernoncashexpense": "null",
    "expectedlifeofarrangement": 15,
    "renderedvalue": 243430,
    "promissorynotesaggregateshares": 485220,
    "promissorynotesaggregatevalue": "null",
    "lossonsettlementondebt": 198939,
    "conversionofstocksharesissued1": 695000,
    "earningspersharebasic": 2.26,
    "proceedsfromcustomers": "null",
    "conversionofstockamountconverted1": 250000,
    "sharebasedgoodsandnonemployeeservicestransactionvaluationmethodriskfreeinterestrate": 0.0294,
    "sharebasedgoodsandnonemployeeservicestransactionvaluationmethodexpectedterm1": 3,
    "sharebasedgoodsandnonemployeeservicestransactionvaluationmethodexpectedvolatilityrate": 1.3937000000000002,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 333855,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpiredinperiod": 350,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 59057,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 333855,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.06,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpiredinperiodweightedaverageexerciseprice": 1.6,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.55,
    "outstandingbeginning": 4.9,
    "sharebasedcompensationarrangementbysharebasedpaymentgrantinperiod": 4.1,
    "outstandingatending": 3.9,
    "exercisableatendofyear": 3.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 559,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 559,
    "weightedaverageremaininglifeinyears": 2.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 333855,
    "warrantexercisepriceincrease": 5.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsissuedinperiod": 333855,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsissuedinperiodweightedaverageexerciseprice": 5.06,
    "saleofstockpricepershare": 0.975,
    "allocatedsharebasedcompensationexpense": 111079,
    "stockcompensationexpenseunamortized": 13269,
    "weightedaverageremaininglife": 17,
    "purchaseofcommonstockshares": 119617,
    "optiongrantable": 652670,
    "percentofissuedandoutstandingshares": 0.2,
    "proceedsfromstockoptionsexercised": 92973,
    "notespayablerelatedpartiescurrentandnoncurrent": "null",
    "stockissuedduringperiodshareissuedforservice": 56345,
    "stockissuedduringperiodsharessharebasedcompensation": 45057,
    "concentrationriskpercentage": 1,
    "netincomelossusedforcalculatingminorityinterest": -8211,
    "averagenoncontrollinginterestpercentageofprofitlosses": 0.35000000000000003,
    "netlossattributabletothenoncontrollinginterest": -7419,
    "noncontrollinginterestbeginningbalance": -117838,
    "noncontrollinginterestendingbalance": -125257,
    "reductionsinotherassetsamount": 6000,
    "considerationamount": 393776,
    "firstpaymentowed": 70138,
    "attorneysfees": 235886,
    "recognizedgainlossoncontingency": -322000,
    "stockoptionsgrant": 10000,
    "termofoptions": "P3Y",
    "receivecommonstockequivalent": 5000,
    "costofgoodsandservicessold": 18946,
    "othercommitment": 28936,
    "royaltydue": 91,
    "businesscombinationcontingentconsiderationliability": "null",
    "paidtoalpinecreek": "null",
    "payablecommitmentdescription": "On any other proprietary implant distribution, that excludes the “treatment”, for alcohol and opioid addiction and for which no other payment is due, the Company shall pay 2.5% of the Company’s gross profit for implant distribution not to exceed $100 per sale. On or about January 1, 2021, Mr. Galligan acquired from Alpine Creek the rights to the royalty agreement by and between the Company and Alpine Creek. As of December 31, 2022 and 2021, there are no payments due",
    "debtconversionconvertedinstrumentsharesissued1": "null",
    "issuanceprice": 2,
    "amountdueoinvestor": "null",
    "royalitypercentageminimum": 0.1,
    "royalitypercentagemaximum": 0.15,
    "businessacquisitionsharesprice": 15,
    "businessacquisitionequityinterestsissuedorissuablenumberofshareissued": 200000,
    "revenuepercentage": 37.5,
    "grossrevenuepershare": 25,
    "percentofaggregatepurchaseprice": 0.65,
    "developmentandexpansionexpenses": "null",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0556,
    "otherincreasedecrease": -0.0102,
    "effectiveincometaxratereconciliationtaxcreditsother": -0.0327,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2227,
    "allowancefordoubtfulaccountsreceivable": 7598,
    "stockoptionsissuedforservices": "null",
    "deferredtaxassetsoperatinglosscarryforwards": "null",
    "deferredtaxassetsother": 367568,
    "deferredtaxassetsgross": "null",
    "royaltyobligation": -306334,
    "deferredtaxliabilitiesother": -55447,
    "deferredincometaxliabilities": 361781,
    "deferredtaxassetsliabilitiesnet": "null",
    "deferredtaxassetsvaluationallowance": "null",
    "operatinglosscarryforwards": 39200000,
    "cumulativechangeinownership": 0.5,
    "federalnetoperatinglossescarryforwarddescription": "As of December 31, 2022, the Company had federal net operating loss carryforwards of approximately $21.9 million, of which $9.3 million, if not utilized, expire by 2029",
    "deferredtaxassetsnet": "null"
  },
  {
    "date": "2021-12-30",
    "symbol": "BICX",
    "period": "FY",
    "entityregistrantname": "BioCorRx Inc.",
    "entitycentralindexkey": 1443863,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "December 31, 2021",
    "entityfilercategory": "Non-accelerated filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2021,
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityfilenumber": "000-54208",
    "entitytaxidentificationnumber": "90-0967447",
    "entityincorporationstatecountrycode": "Nevada",
    "entityaddressaddressline1": "2390 East Orangewood Avenue",
    "entityaddressaddressline2": "Suite 500",
    "entityaddresscityortown": "Anaheim",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92806,
    "localphonenumber": "462-4880",
    "cityareacode": 714,
    "auditorname": "Friedman LLP",
    "auditorlocation": "Marlton, New Jersey",
    "auditorfirmid": 711,
    "cash": 85838,
    "accountsreceivablenet": 1500,
    "grantsreceivable": 56359,
    "prepaidexpensecurrent": 84629,
    "assetscurrent": 228326,
    "propertyplantandequipmentnet": 102843,
    "operatingleaserightofuseasset": 384921,
    "finitelivedintangibleassetsnet": 11385,
    "finitelivedintangibleassetsgross": 47980,
    "longterminvestments": 44520,
    "otherassets": 103885,
    "assets": 819975,
    "accountspayableandaccruedliabilitiescurrent": "null",
    "deferredrevenuecurrent": 34981,
    "operatingleaseliabilitycurrent": 119733,
    "notespayablecurrent": 200000,
    "notespayablerelatedpartiesclassifiedcurrent": 125000,
    "ppploanshortterm": 31580,
    "liabilitiescurrent": "null",
    "ppploanlongterm": 99860,
    "eidlloanlongterm": 74300,
    "duetorelatedpartiescurrent": "null",
    "operatingleaseliability": 315672,
    "deferredrevenuenoncurrent": 37301,
    "liabilities": "null",
    "commonstockvalue": 6699,
    "commonstocksharessubscriptions": 100000,
    "additionalpaidincapital": "null",
    "retainedearningsaccumulateddeficit": "-null",
    "stockholdersequity": "-null",
    "minorityinterest": -117838,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": -117838,
    "liabilitiesandstockholdersequity": 819975,
    "preferredstockvalue": 5616,
    "royaltyobligationrelatedpartiesnetofdiscount": "null",
    "accountspayableandaccruedexpensesincludingrelatedpartypayables": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "preferredstocksharesauthorized": 600000,
    "preferredstocksharesdesignated": 160000,
    "preferredstocksharesissued": 160000,
    "preferredstocksharesoutstanding": 80000,
    "revenues": 48272,
    "costofrevenue": 5881,
    "researchanddevelopmentexpense": "null",
    "generalandadministrativeexpense": "null",
    "impairmentofintangibleassetsfinitelived": 141480,
    "depreciationandamortization": 64328,
    "operatingexpenses": "null",
    "operatingincomeloss": "-null",
    "interestincomeexpensenet": -565684,
    "grantincome": 835924,
    "othermiscellaneousincome": 29229,
    "nonoperatingincomeexpense": 299469,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": "-null",
    "netincomeloss": -2384,
    "noninterestincome": 2384,
    "warrantdownroundfeatureincreasedecreaseinequityamount": -70127,
    "netincomelossattributabletononcontrollinginterest": "-null",
    "earningspersharebasicanddiluted": -0.81,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "sharesissued": "null",
    "stockissuedduringperiodsharesissuedforservices": 31392,
    "stockissuedduringperiodvalueissuedforservices": 102500,
    "stockgrantedduringperiodvaluesharebasedcompensation": 8715,
    "commonstockissuedinconnectionwithsubscriptionagreementshares": "null",
    "commonstockissuedinconnectionwithsubscriptionagreementamount": "null",
    "forwardcontractindexedtoissuersequityshares": 47086,
    "conversionofstockamountconverted1": "null",
    "recognitionofdownroundfeatureinconnectionwithexerciseofwarrants": -70127,
    "amortizationofdiscountonroyaltyobligation": 477436,
    "financeleaserightofuseassetamortization": 104615,
    "sharebasedcompensation": 209515,
    "gainslossesonextinguishmentofdebt": -28229,
    "increasedecreaseinaccountsreceivable": -1000,
    "increasedecreaseingrantreceivable": 168520,
    "increasedecreaseinprepaidexpense": 72864,
    "increasedecreaseinaccountspayableandaccruedliabilities": 698631,
    "increasedecreaseinotherdeferredliability": -106290,
    "deferredrevenuegrant": -65560,
    "increasedecreaseindeferredrevenue": -63330,
    "netcashprovidedbyusedinoperatingactivities": "-null",
    "paymentstoacquireoilandgasequipment": 2017,
    "paymentstoacquirepropertyplantandequipment": 47980,
    "netcashprovidedbyusedininvestingactivities": -49997,
    "proceedsfromissuanceofcommonstock": "null",
    "advancesfromsba": 5000,
    "proceedsfromppploan": 131440,
    "proceedsfromnotespayable": 200000,
    "proceedsfromrelatedpartydebt": 500000,
    "netcashprovidedbyusedinfinancingactivities": "null",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -506215,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 85838,
    "recognitionofdownroundfeature": 70127,
    "conversionofstockamountissued1": 47,
    "salescommissionsandfees": 1500,
    "investmentcompanydividenddistribution": 35481,
    "membershipprogramfees": 11291,
    "deferredrevenueshortterm": 72282,
    "deferredrevenuelongterm": 34981,
    "deferredrevenue": 37301,
    "sharesunderlyingoptionsoutstanding": 815351,
    "convertiblepreferredstockoutstanding": 240000,
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "collateralizedfinancings": 47980,
    "variableinterestentityownershippercentage": 0.1,
    "deferredrevenuerevenuerecognized1": 34980,
    "assetimpairmentcharges": 141480,
    "advertisingexpense": 426917,
    "prepaidinsurance": 3680,
    "prepaidsubscriptionservices": 79455,
    "otherprepaidexpensecurrent": 1494,
    "depreciation": 27778,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 91708,
    "total": 194551,
    "propertyplantandequipmentgross": 42288,
    "totalleaseliability": 435405,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearfour": 150266,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 154771,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearfive": 159420,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 31690,
    "presentvaluediscount": -60742,
    "leaseliability": 435405,
    "operatingleaseexpense": 144057,
    "operatingleasesrentexpensenet": 144057,
    "acquiredfinitelivedintangibleassetsweightedaverageusefullife": 3.1,
    "weightedaveragediscountrate": 0.08,
    "totalleaseexpense": 143447,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1169,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1169,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1169,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1169,
    "finitelivedintangibleassetsamortizationexpenserollingafteryearfive": 6709,
    "totalfutureamortizationofthepatents": 11385,
    "amortizationofintangibleassets": 1180,
    "accumulatedamortization": 3815,
    "goodwillimpairmentloss": 141480,
    "finitelivedintangibleassetusefullife": 5,
    "accountspayablecurrent": "null",
    "interestanddividendspayablecurrent": "null",
    "interestpayableonnotespayablerelatedparties": 224592,
    "deferredinsurance": 2561,
    "interestpayableoneidlloan": 4076,
    "accruedliabilitiesandotherliabilities": 983,
    "accruedexpenses": 25670,
    "interestexpense": 15616,
    "interestexpenserelatedparty": 2786,
    "accumulatedinterest": 224592,
    "duefromrelatedparties": 1500,
    "outstandingprincipalbalanceonissuanceofpromissorynote": 163610,
    "futureprincipalpayments": 31580,
    "futureprincipalpaymentsone": 26082,
    "futureprincipalpaymentstwo": 26344,
    "futureprincipalpaymentsthree": 26609,
    "futureprincipalpaymentsfive": 20825,
    "totafutureprincipalpayments": 131440,
    "accumulatedinterestonrelatedpartiesnotespayable": 983,
    "proceedsfromloanoriginations1": 74300,
    "capitalleasesfutureminimumpaymentsreceivabledueinrollingyeartwo": 279,
    "capitalleasesfutureminimumpaymentsduecurrent": 1608,
    "capitalleasesfutureminimumpaymentsreceivabledueinrollingyearthree": 1661,
    "capitalleasesfutureminimumpaymentsreceivabledueinrollingyearfour": 1732,
    "capitalleasesfutureminimumpaymentsreceivabledueinrollingyearfive": 1799,
    "capitalleasesfutureminimumpaymentsreceivabledueinrollingafteryearfive": 67221,
    "capitalleasesfutureminimumpaymentsreceivable": 74300,
    "balanceofprincipalandinterestpayableperioddescription": "the balance of principal and interest will be payable thirty (30) years from the date of the promissory note",
    "shorttermdebtinterestrateincrease": 0.0375,
    "monthlypaymentsofprincipalandinterest": 363,
    "adjustmentforamortization": 477436,
    "othernoncashexpense": "null",
    "commonstocksharesissueddescripiton": "the J and R Galligan Revocable Trust, managed by Mr. Joseph Galligan, a holder of between 5% and 10% of the Company’s shares of common stock",
    "expectedlifeofarrangement": 15,
    "conditionstousefundsdescription": "the Company will use no less than 65% of the proceeds of the aggregate Purchase Price of the Lucido Subscription and Royalty Agreement exclusively to develop, launch and expand the Company’s weight loss program (“Business”) including sales and marketing activities directly related to the Business, and shall be free to use up to 35% of the aggregate Purchase Price of the Lucido Subscription and Royalty Agreement for general working capital and administration, and for further product development.",
    "classofwarrantorrightunissued": 47086,
    "shareprice": 2,
    "riskfreeinterestrate": 0.0029,
    "expectedtermyears": 5,
    "expectedvolatility": 1.3727,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 815351,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 363281,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionforfeituresandexpirationsinperiod": -13280,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 815351,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 7.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.85,
    "outstandingbeginning": 5.8,
    "sharebasedcompensationarrangementbysharebasedpaymentgrantinperiod": "P0Y",
    "outstandingatending": 4.9,
    "exercisableatendofyear": 4.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 795115,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 795115,
    "weightedaverageremaininglifeinyears": 4.9,
    "warrantexpired": -62500,
    "warrantexercised": 10000,
    "weightedaverageexercisepricebeginning": 89,
    "weightedaverageexercisepriceexercised": 20,
    "weightedaverageexercisepriceexpired": 100,
    "allocatedsharebasedcompensationexpense": 8715,
    "saleofstockpricepershare": 4.33,
    "stockcompensationexpenseunamortized": 3135,
    "weightedaverageremaininglife": "P3Y",
    "exercisepriceofwarrants": 2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 3.81,
    "debtconversionconvertedinstrumentwarrantsoroptionsissued1": 100000,
    "conversionofstocksharesissued1": 450000,
    "planterminationtermperiod": "P10Y",
    "optiongrantable": 86719,
    "notesreceivablerelatedparties": "null",
    "impairedfinancingreceivableunpaidprincipalbalance": 210,
    "commonstockissuablevalue": 5000,
    "officerscompensation": 15000,
    "concentrationriskpercentage1": 1,
    "netincomelossusedforcalculatingminorityinterest": -9853,
    "averagenoncontrollinginterestpercentageofprofitlosses": 0.242,
    "netlossattributabletothenoncontrollinginterest": -2384,
    "noncontrollinginterestbeginningbalance": -115454,
    "noncontrollinginterestendingbalance": -117838,
    "othercommitment": 28936,
    "royaltydue": 91,
    "businesscombinationcontingentconsiderationliability": "null",
    "debtinstrumentdescription": "into six scientific advisory board agreements. In compensation for services, each advisory board member shall receive common stock equivalent to $5,000 on the last day of such quarter when meetings are held",
    "debtconversionconvertedinstrumentsharesissued1": "null",
    "issuanceprice": 2,
    "grossproceeds": "null",
    "developmentandexpansionexpenses": "null",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0698,
    "otherincreasedecrease": -0.08800000000000001,
    "effectiveincometaxratereconciliationtaxcreditsother": -0.0001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.1917,
    "allowancefordoubtfulaccountsreceivable": 7598,
    "stockoptionsissuedforservices": "null",
    "deferredtaxassetsoperatinglosscarryforwards": "null",
    "deferredtaxassetsother": 401918,
    "deferredtaxassetsgross": "null",
    "royaltyobligation": -439938,
    "deferredincometaxliabilities": 439938,
    "deferredtaxassetsliabilitiesnet": "null",
    "deferredtaxassetsvaluationallowance": "null",
    "federalnetoperatinglossescarryforwardexpiryperiod": 2033,
    "cumulativechangeinownership": 0.5,
    "federalnetoperatinglossescarryforwarddescription": "The Company has Federal net operating losses (“NOLs”) of approximately $9.3 million which begin to expire in the years beginning in 2033 and $11.8 million that do not expire",
    "federalandstatetaxcredits": "The Company also has federal credits that begin to expire 2031 and state tax credits that may be carried forward indefinitely",
    "deferredtaxassetsnet": "null"
  },
  {
    "date": "2020-12-30",
    "symbol": "BICX",
    "period": "FY",
    "entityregistrantname": "BioCorRx Inc.",
    "entitycentralindexkey": 1443863,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "2020-12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityinteractivedatacurrent": "Yes",
    "cash": 592053,
    "accountsreceivablenet": 500,
    "grantsreceivable": 224879,
    "prepaidexpensecurrent": 157493,
    "assetscurrent": 974925,
    "propertyplantandequipmentnet": 128605,
    "operatingleaserightofuseasset": 489536,
    "finitelivedpatentsgross": 12564,
    "finitelivedintangibleassetsnet": 176850,
    "longterminvestments": 44520,
    "otherassets": 233934,
    "assets": 1827000,
    "accountspayableandaccruedliabilitiescurrent": 2490158,
    "deferredrevenuecurrent": 63331,
    "deferredrentcredit": 764,
    "leaseliabilityshortterm": 106290,
    "notespayable": 21480,
    "notespayablerelatedpartiesclassifiedcurrent": 125000,
    "ppploanshortterm": 15445,
    "liabilitiescurrent": 3052374,
    "ppploanlongterm": 12555,
    "eidlloanlongterm": 74300,
    "duetorelatedpartiescurrent": 2390438,
    "operatingleaseliability": 435405,
    "deferredrevenuenoncurrent": 72281,
    "liabilities": 6037353,
    "commonstockvalue": 5463,
    "commonstocksharessubscriptions": 100000,
    "additionalpaidincapital": 60466333,
    "retainedearningsaccumulateddeficit": -64688311,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": -4094899,
    "minorityinterest": -115454,
    "stockholdersequity": -115454,
    "liabilitiesandstockholdersequity": 1827000,
    "preferredstockvalue": 5616,
    "royaltyobligationrelatedpartiesnetofdiscount": 6331662,
    "accountspayableandaccruedexpensesincludingrelatedpartypayables": 686068,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 750000000,
    "commonstocksharesissued": 59670,
    "commonstocksharesoutstanding": 5463444,
    "preferredstocksharesauthorized": 160000,
    "preferredstocksharesdesignated": 160000,
    "preferredstocksharesissued": 160000,
    "preferredstocksharesoutstanding": 160000,
    "revenues": 122621,
    "costofrevenue": 95948,
    "researchanddevelopmentexpense": 4273815,
    "generalandadministrativeexpense": 3167577,
    "depreciationandamortization": 77254,
    "operatingexpenses": 7614594,
    "operatingincomeloss": -7491973,
    "interestexpense": 510959,
    "grantincome": 4464626,
    "othermiscellaneousincome": 31799,
    "nonoperatingincomeexpense": 3985466,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -3506507,
    "netincomeloss": -34276,
    "incomelossfromcontinuingoperationsincludingportionattributabletononcontrollinginterest": 34276,
    "netincomelossattributabletononcontrollinginterest": -3472231,
    "earningspersharebasicanddiluted": -0.65,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 5377670,
    "sharesissued": 5463444,
    "stockissuedduringperiodsharesissuedforservices": 136592,
    "stockissuedduringperiodvalueissuedforservices": 278280,
    "stockgrantedduringperiodvaluesharebasedcompensation": 76760,
    "amortizationofdiscountonroyaltyobligation": 480656,
    "financeleaserightofuseassetamortization": 89517,
    "sharebasedcompensation": 355040,
    "gainslossesonextinguishmentofdebt": -26000,
    "increasedecreaseinaccountsreceivable": 250,
    "increasedecreaseinaccountsandotherreceivables": -38211,
    "increasedecreaseinprepaidexpense": 55790,
    "increasedecreaseinaccountspayableandaccruedliabilities": 483778,
    "paymentsfordeposits": -2584,
    "accretionofleaseliability": -83790,
    "deferredrevenuegrant": 65560,
    "increasedecreaseindeferredrevenue": -102625,
    "netcashprovidedbyusedinoperatingactivities": -2151872,
    "purchaseofequipment": -9227,
    "netcashprovidedbyusedininvestingactivities": -9227,
    "proceedsfromissuanceofcommonstock": 100000,
    "advancesfromsba": 5000,
    "proceedsfromloanoriginations1": 74300,
    "proceedsfromppploan": 28000,
    "netcashprovidedbyusedinfinancingactivities": 107300,
    "cashandcashequivalentsperiodincreasedecrease": -2053799,
    "cashandcashequivalentsatcarryingvalue": 592053,
    "recordrighttouseassetsperasc842netofdeferredrent": 120346,
    "recordleaseliabilityperasc842": 120346,
    "equitymethodinvestmentownershippercentage": 0.05,
    "descriptionofreversestocksplit": "Effective January 22, 2019, the Company amended its Articles of Incorporation to implement a reverse stock split in the ratio of 1 share for every 100 shares of common stock. As a result, 259,984,655 shares of the Company&#8217;s common stock were exchanged for 2,599,847 shares of the Company&#8217;s common stock. These consolidated financial statements have been retroactively restated to reflect the reverse stock split (See Note 15).",
    "salescommissionsandfees": 13500,
    "investmentcompanydividenddistribution": 107169,
    "membershipprogramfees": 1952,
    "deferredrevenue": 135612,
    "cashpaymentsreceived": 6496,
    "netsalesrecognized": -109121,
    "sharesunderlyingoptionsoutstanding": 828631,
    "sharesunderlyingwarrantsoutstanding": 72500,
    "convertiblepreferredstockoutstanding": 240000,
    "weightedaveragenumberofdilutedsharesoutstanding": 1141131,
    "advertisingexpense": 443175,
    "deferredincometaxexpensebenefit": 65560,
    "revenuerelatedtoaccessfees": 13500,
    "paymentonaccountsreceivable": 186665,
    "royaltyobligationsdescription": "The Company accounted for royalty obligations as debt in accordance with ASC 470-10-25 and derived a debt discount, which is amortized using the effective interest method over the expected life of the arrangement, which is 15 years. The Company has no obligation to repay the then outstanding balance if during the expected life of 15 years the treatment is discontinued. ",
    "royaltyexpense": 7171200,
    "propertyplantandequipmentusefullife": "P15Y",
    "workingcapitaldeficiency": -2077449,
    "prepaidinsurance": 8152,
    "prepaidsubscriptionservices": 78641,
    "deferredtaxassetsinprocessresearchanddevelopment": 65560,
    "otherprepaidexpensecurrent": 5140,
    "total": 157493,
    "propertyplantandequipmentgross": 42288,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 63930,
    "depreciation": 28922,
    "totalleaseliability": 541695,
    "operatingleaseliabilitycurrent": 106290,
    "operatingleaseliabilitynoncurrent": 435405,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearthree": 145813,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearfour": 150266,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 154771,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearfive": 159420,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 31690,
    "presentvaluediscount": -100265,
    "leaseliability": 541695,
    "operatingleaseexpense": 118316,
    "operatingleasesrentexpensenet": 118316,
    "weightedaverageremainingleaseterm": "P4Y3M18D",
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "leasecommencementdate": "2016-07-01",
    "balanceattributedtorightofuseassets": 620679,
    "leaseexpirationdate1": "2019-06-30",
    "totalleaseexpense": 105121,
    "leaseliabilityuponadoptionofasc842": 26229,
    "recordrighttouseassetsuponadoptionofasc842": 25465,
    "futureamortizationoftheintellectualpropertytwothousandtwentyone": 47160,
    "futureamortizationoftheintellectualpropertytwothousandtwentytwo": 47160,
    "futureamortizationoftheintellectualpropertytwothousandtwentythree": 47160,
    "futureamortizationoftheintellectualpropertytwothousandtwentyfour": 35370,
    "totalfutureamortizationoftheintellectualproperty": 176850,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1169,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1169,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1169,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1169,
    "finitelivedintangibleassetsamortizationexpenserollingafteryearfive": 7888,
    "totalfutureamortizationofthepatents": 12564,
    "amortizationofintangibleassets": 47160,
    "accumulatedamortization": 59150,
    "accountspayablecurrent": 1180703,
    "interestanddividendspayablecurrent": 1138157,
    "interestpayableonnotespayablerelatedparties": 155768,
    "deferredinsurance": 5930,
    "interestpayableoneidlloan": 1290,
    "accruedliabilitiesandotherliabilities": 179,
    "accruedexpenses": 8131,
    "notespayablecurrent": 21480,
    "debtconversionconvertedinstrumentsharesissued1": 2227575,
    "additionalinvestment": 1660000,
    "conversioninterestpayable": 1138157,
    "interestexpenserelatedparty": 29865,
    "duefromrelatedparties": 1500,
    "outstandingprincipalbalanceonissuanceofpromissorynote": 163610,
    "debtinstrumentmaturitydatedescription": "The principal will due by December 31, 2021, and the full principal will due by May 13, 2022",
    "debtinstrumentterm": "P2Y",
    "debtinstrumentinterestratestatedpercentage": 0.01,
    "monthlypaymentsofprincipalandinterest": 363,
    "capitalleasesfutureminimumpaymentsduecurrent": 279,
    "capitalleasesfutureminimumpaymentsreceivabledueinrollingyearthree": 1608,
    "capitalleasesfutureminimumpaymentsreceivabledueinrollingyearfour": 1661,
    "capitalleasesfutureminimumpaymentsreceivabledueinrollingyearfive": 1732,
    "capitalleasesfutureminimumpaymentsreceivabledueinrollingafteryearfive": 69020,
    "capitalleasesfutureminimumpaymentsreceivable": 74300,
    "accumulatedinterestoneidlloan": 1290,
    "debtinstrumentinterestrateduringperiod": 0.0375,
    "othernoncashexpense": 7171200,
    "expectedlifeofthearrangement": "P15Y",
    "conditionstousefundsdescription": "The Company will use no less than 65% of the proceeds of the aggregate Purchase Price of the Lucido Subscription and Royalty Agreement exclusively to develop, launch and expand the Company&#8217;s weight loss program (&#8220;Business&#8221;) including sales and marketing activities directly related to the Business, and shall be free to use up to 35% of the aggregate Purchase Price of the Lucido Subscription and Royalty Agreement",
    "conversionofstocksharesissued1": 290879,
    "stockholdersequityreversestocksplit": "The ratio of 1 share for every 100 shares of common stock.",
    "commonstockforservicesrenderedshares": 136592,
    "commonstockforservicesrenderedamount": 278280,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0029,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.3727,
    "outstandingbeginningnumberofshares": 822797,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 145000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": -10000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 72500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 72500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexercisepriceoutstandingbeginning": 8.03,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y5M30D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm2": "P3Y5M30D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P5Y9M18D",
    "exercisableatendofyear": "P5Y9M18D",
    "outstandingbeginningaggregateintrinsicvalue": 244603,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P5M16D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 447447,
    "numberoutstanding": 72500,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 100,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageexerciseprice1": 100,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P5M16D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumberoutstandingbeginning": 72500,
    "weightedaverageexercisepriceissued": 89,
    "weightedaverageexercisepriceending": 89,
    "allocatedsharebasedcompensationexpense": 76760,
    "stockcompensationexpenseunamortized": 11850,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm1": "P7Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 0.95,
    "planterminationterm": "P10Y",
    "optiongrantsvalue": 22246,
    "optiongrantable": 145879,
    "relatedpartypayables": 686068,
    "impairedfinancingreceivableunpaidprincipalbalance": 210,
    "salary": 175000,
    "commonstockissuablevalue": 5000,
    "officerscompensation": 15000,
    "commonstocksharesissuedtorelatedparty": 59670,
    "commonstockvalueissuedtorelatedparty": 100000,
    "concentrationriskpercentage1": 0.58,
    "netincomelossusedforcalculatingminorityinterest": -141638,
    "netlossattributabletothenoncontrollinginterest": -34276,
    "averagenoncontrollinginterestpercentageofprofitlosses": 0.242,
    "noncontrollinginterestbeginningbalance": -81178,
    "noncontrollinginterestendingbalance": -115454,
    "researchanddevelopmentsexpenses": 393980,
    "royaltydue": 91,
    "remunerationamount": 5500,
    "debtinstrumentdescription": "Into two scientific advisory board agreements. In compensation for services, each advisory board member shall receive common stock equivalent to $5,000 on the last day of such quarter when meetings are held. ",
    "estimatedcost": 578500,
    "othercommitment": 178920,
    "issuanceprice": 2,
    "grossproceeds": 10000000,
    "developmentandexpansionexpenses": 3000000,
    "businesscombinationcontingentconsiderationliability": 1531926,
    "payablecommitmentdescription": "On any other proprietary implant distribution, that excludes the &#8220;treatment&#8221;, for alcohol and opioid addiction and for which no other payment is due, the Company shall pay 2.5% of the Company&#8217;s gross profit for implant distribution not to exceed $100 per sale. ",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0698,
    "effectiveincometaxratereconciliationtaxcreditsother": -0.0004,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2794,
    "allowancefordoubtfulaccountsreceivable": 7598,
    "stockoptionsissuedforservices": 1731729,
    "deferredtaxassetsoperatinglosscarryforwards": 5405023,
    "deferredtaxassetsother": 84081,
    "deferredtaxassetsgross": 7228431,
    "royaltyobligation": -573541,
    "deferredincometaxliabilities": -573541,
    "deferredtaxassetsnet": 6654890,
    "deferredtaxassetsvaluationallowance": -6654890,
    "federalnetoperatinglossescarryforwardexpiryperiod": 2033,
    "operatinglosscarryforwards": 9300000,
    "cumulativechangeinownership": 0.5,
    "federalnetoperatinglossescarryforwarddescription": "The company has Federal net operating losses (\"NOLs\")  of approximately $9.3 million which begin to expire in the years beginning in 2033 and $10 million that do not expire.",
    "federalandstatetaxcredits": "The company also has federal credits that begin to expire 2031 and state tax credits that may be carried forward indefinitely."
  },
  {
    "date": "2019-12-30",
    "symbol": "BICX",
    "period": "FY",
    "entityregistrantname": "BioCorRx Inc.",
    "entitycentralindexkey": 1443863,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "2019-12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "entityfilenumber": "000-54208",
    "entityaddressaddressline1": "2390 East Orangewood Avenue",
    "entityaddressaddressline2": "Suite 500",
    "entityaddresspostalzipcode": 92806,
    "entitytaxidentificationnumber": 900967447,
    "entityaddresscityortown": "Anaheim",
    "localphonenumber": "462-4880",
    "cityareacode": 714,
    "entityaddressstateorprovince": "CALIFORNIA",
    "cash": 2645852,
    "accountsreceivablenet": 750,
    "grantsreceivable": 186668,
    "prepaidexpensecurrent": 213283,
    "assetscurrent": 3046553,
    "propertyplantandequipmentnet": 148300,
    "operatingleaserightofuseasset": 458707,
    "finitelivedpatentsgross": 13736,
    "intellectualpropertynet": 224010,
    "longterminvestments": 41936,
    "otherassets": 279682,
    "assets": 3933242,
    "accountspayableandaccruedliabilitiescurrent": 2027380,
    "deferredrevenuecurrent": 134924,
    "leaseliabilityshortterm": 76977,
    "notespayablecurrent": 125000,
    "notespayable": 290110,
    "liabilitiescurrent": 2550871,
    "royaltyobligationrelatedparties": 1909782,
    "deferredrevenuenoncurrent": 103313,
    "leaseliabilitieslongterm": 428162,
    "liabilities": 4992128,
    "preferredstockvalue": 5616,
    "commonstockvalue": 5327,
    "commonstocksharessubscriptions": 100000,
    "additionalpaidincapital": 60111429,
    "retainedearningsaccumulateddeficit": -61216080,
    "stockholdersequityincludingportionattributabletononcontrollinginterest": -977708,
    "minorityinterest": -81178,
    "stockholdersequity": -1058886,
    "liabilitiesandstockholdersequity": 3933242,
    "notespayablerelatedpartiesclassifiedcurrent": 391209,
    "royaltyobligationrelatedpartiesnetofdiscount": 6812318,
    "preferredstocksharesauthorized": 160000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 750000000,
    "commonstocksharesissued": 5326852,
    "commonstocksharesoutstanding": 5326852,
    "preferredstocksharesissued": 160000,
    "preferredstocksharesoutstanding": 160000,
    "revenues": 240259,
    "costofrevenue": 81670,
    "researchanddevelopmentexpense": 1125098,
    "generalandadministrativeexpense": 4565346,
    "depreciationandamortization": 29413,
    "operatingexpenses": 5801527,
    "operatingincomeloss": -5561268,
    "interestexpense": -1622426,
    "grantincome": 1091061,
    "lossonsaleoffixedassets": 1902,
    "othermiscellaneousincome": 46214,
    "nonoperatingincomeexpense": -487053,
    "incomelossfromcontinuingoperationsbeforeinterestexpenseinterestincomeincometaxesextraordinaryitemsnoncontrollinginterestsnet": -6048321,
    "netincomeloss": -6048321,
    "netincomelossattributabletoredeemablenoncontrollinginterest": 8691,
    "netincomelossattributabletononcontrollinginterest": -6039630,
    "earningspersharebasicanddiluted": -1.71,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 3523208,
    "sharesissued": 5326852,
    "commonstockissuedforservicesrenderedshares": 75017,
    "commonstockissuedforservicesrenderedamount": 271050,
    "saleofcommonstockshares": 22222,
    "saleofcommonstockamount": 100000,
    "sharebasecompensation": 1694653,
    "profitloss": -6048321,
    "commonstockissuedinconnectionwithnoteconversionamount": 4160000,
    "commonstockissuedinconnectionwithnoteconversionshares": 2227575,
    "commonstockissuedinconnectionwithsubscriptionandroyaltyagreementshares": 400000,
    "commonstockissuedinconnectionwithsubscriptionandroyaltyagreementamount": 4449100,
    "interestexpensepaidwithcommonstockamount": 21000,
    "interestexpensepaidwithcommonstockshares": 3842,
    "roundupsharesforreversestocksplitamount": -1,
    "roundupsharesforreversestocksplitshares": 849,
    "amortizationofdiscountonroyaltyobligation": 358882,
    "provisionfordoubtfulaccounts": 2400,
    "interestexpensepaidwithcommonstock": 21000,
    "amortizationofdebtdiscountpremium": 783650,
    "financeleaserightofuseassetamortization": 67091,
    "sharebasedcompensation": 1965703,
    "increasedecreaseinaccountsreceivable": 4850,
    "increasedecreaseinaccountsandotherreceivables": -186668,
    "increasedecreaseinprepaidexpense": -181825,
    "increasedecreaseinaccountspayableandaccruedliabilities": 473490,
    "deposits": -28514,
    "leaseliabilities": -21420,
    "increasedecreaseindeferredrevenue": -178760,
    "netcashprovidedbyusedinoperatingactivities": -2937127,
    "paymentstoacquireproductiveassets": -122593,
    "proceedsfromsaleofpropertyandequipment": 800,
    "netcashprovidedbyusedininvestingactivities": -121793,
    "proceedsfromissuanceofcommonstock": 100000,
    "proceedsfromcommonstocksubscriptionandroyaltyagreement1": 6000000,
    "repaymentsofnotespayable": -675000,
    "netcashprovidedbyusedinfinancingactivities": 5425000,
    "cashandcashequivalentsperiodincreasedecrease": 2366080,
    "interestpaidnet": 61397,
    "recordrighttouseassetsperasc842netofdeferredrent": 525798,
    "recordleaseliabilityperasc842": 526559,
    "commonstockissuedinconnectionwithconversionofnotespayable": 4160000,
    "stateofincorporation": "Nevada",
    "descriptionofreversestocksplit": "Effective January 22, 2019, the Company amended its Articles of Incorporation to implement a reverse stock split in the ratio of 1 share for every 100 shares of common stock. As a result, 259,984,655 shares of the Company&#146;s common stock were exchanged for 2,599,847 shares of the Company&#146;s common stock. These consolidated financial statements have been retroactively restated to reflect the reverse stock split (See Note 13).",
    "salescommissionsandfees": 29150,
    "investmentcompanydividenddistribution": 207110,
    "membershipprogramfees": 3999,
    "cashpaymentsreceived": 32349,
    "netsalesrecognized": -211109,
    "deferredrevenue": 238237,
    "sharesunderlyingoptionsoutstanding": 822797,
    "sharesunderlyingwarrantsoutstanding": 72500,
    "convertiblepreferredstockoutstanding": 240000,
    "weightedaveragenumberofdilutedsharesoutstanding": 1135297,
    "advertisingexpense": 436205,
    "revenuerelatedtoaccessfees": 29150,
    "discountrateonfacevalue": 0.08,
    "grantfunds": 932745,
    "royaltyobligationsdescription": "The Company accounted for this transaction as debt in accordance with ASC 470-10-25 and derived a debt discount, which is amortized using the effective interest method over the expected life of the arrangement, which is 15 years. The Company has no obligation to repay the then outstanding balance if during the expected life of 15 years the treatment is discontinued. ",
    "royaltyexpense": 7171200,
    "descriptionoflikelihoodsettlement": "The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.",
    "recordrighttouseassetsuponadoptionofasc842": 25465,
    "deferredrentcredit": 764,
    "leaseliabilityuponadoptionofasc842": 26229,
    "propertyplantandequipmentusefullife": "P15Y",
    "workingcapitaldeficiency": -495682,
    "subscriptionamount": 6000000,
    "prepaidinsurance": 81475,
    "prepaidsubscriptionservices": 127208,
    "otherprepaidexpensecurrent": 4600,
    "total": 213283,
    "propertyplantandequipmentgross": 98373,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 35008,
    "depreciation": 15959,
    "operatingleaseliability": 505139,
    "operatingleaseliabilitycurrent": -76977,
    "operatingleaseliabilitynoncurrent": 428162,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyeartwo": 114625,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearthree": 118065,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearfour": 121606,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 125255,
    "lesseeoperatingleaseliabilitypaymentsdueinrollingyearfive": 140030,
    "presentvaluediscount": -114442,
    "operatingleaseexpense": 78034,
    "operatingleasesrentexpensenet": 78034,
    "operatingleaseweightedaverageremainingleaseterm1": "P4Y10M24D",
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "lesseeoperatingleaseliabilitypaymentsduenextrollingtwelvemonths": 26844,
    "leasecommencementdate": "2016-07-01",
    "leaseexpirationdate1": "2019-06-30",
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 201263,
    "totalleaseexpense": 32367,
    "futureamortizationoftheintellectualpropertytwothousandtwenty": 47160,
    "futureamortizationoftheintellectualpropertytwothousandtwentyone": 47160,
    "futureamortizationoftheintellectualpropertytwothousandtwentytwo": 47160,
    "futureamortizationoftheintellectualpropertytwothousandtwentythree": 47160,
    "futureamortizationoftheintellectualpropertytwothousandtwentyfour": 35370,
    "totalfutureamortizationoftheintellectualproperty": 224010,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1172,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1169,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1169,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1169,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 9057,
    "totalfutureamortizationofthepatents": 13736,
    "amortizationoffinancingcosts": 1464,
    "finitelivedintangibleassetusefullife": "P13Y",
    "amortizationofintangibleassets": 11990,
    "accountspayablecurrent": 709353,
    "interestanddividendspayablecurrent": 1138157,
    "interestpayableonnotespayablerelatedparties": 125903,
    "deferredinsurance": 53967,
    "debtdiscounttocurrentperiodinterestexpense": 127419,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "interestanddebtexpense": 8110,
    "fairvalueassumptionsvolatilityrate": 1.7701,
    "riskfreerate": 0.0291,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 7.3,
    "adjustmentforamortization": 656231,
    "interestexpensedebt": 389330,
    "debtconversionconvertedinstrumentsharesissued1": 2227575,
    "additionalinvestment": 1660000,
    "conversioninterestpayable": 1138157,
    "interestexpenserelatedparty": 29783,
    "outstandingprincipalbalanceonissuenceofpromissorynote": 163610,
    "duefromrelatedparties": 1500,
    "commonstockissuedaggregateshares": 2227575,
    "convertibleamountofaggregatesharesissued": 4160000,
    "commonstockissuedforinterestshares": 3842,
    "commonstockissuedforinterestvalues": 21000,
    "stockissuedduringperiodvalueissuedforservices": 12000,
    "commonstockforservicesrenderedamount": 100000,
    "commonstockforservicesrenderedshare": 29111,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0258,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.4311,
    "outstandingbeginningnumberofshares": 791850,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 53280,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 12750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": -20833,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 72500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 72500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexercisepriceoutstandingbeginning": 8.09,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 25,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm2": "P2Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y6M",
    "exercisableatendofyear": "P6Y7M6D",
    "outstandingbeginningaggregateintrinsicvalue": 1188065,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 244603,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 244603,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P1Y5M16D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 72500,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 100,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageexerciseprice1": 89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P1Y5M16D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumberoutstandingbeginning": 85250,
    "outstandingbeginningbalance": 79.4,
    "allocatedsharebasedcompensationexpense": 1694653,
    "stockcompensationexpenseunamortized": 26999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm1": "P10Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 2.75,
    "optiongrantable": 145879,
    "conversionofstocksharesissued1": 290879,
    "planterminationterm": "P10Y",
    "optiongrantsvalue": 233111,
    "impairedfinancingreceivableunpaidprincipalbalance": 210,
    "proceedsfromroyalty": 6000000,
    "salary": 175000,
    "commonstockissuablevalue": 5000,
    "officerscompensation": 15000,
    "monthlyremuneration": 14583,
    "legalfees": 250000,
    "concentrationriskpercentage1": 0.15,
    "majorcustomersaccountsreceivable": 750,
    "netincomelossusedforcalculatingminorityinterest": -35914,
    "netlossattributabletothenoncontrollinginterest": -8691,
    "averagenoncontrollinginterestpercentageofprofitlosses": 0.242,
    "noncontrollinginterestbeginningbalance": -72487,
    "noncontrollinginterestendingbalance": -81178,
    "licensingrightscarryingvalue": 250000,
    "researchanddevelopmentexpenses": 382915,
    "estimatedcost": 578500,
    "considerationamount": 343648,
    "convertiblenotespayable": 4160000,
    "issuanceprice": 2,
    "grossproceeds": 10000000,
    "developmentandexpansionexpenses": 3000000,
    "payablestoalpinecreek": 85805,
    "payablecommitmentdescription": "On any other proprietary implant distribution, that excludes the &#8220;treatment&#8221;, for alcohol and opioid addiction and for which no other payment is due, the Company shall pay 2.5% of the Company&#8217;s gross profit for implant distribution not to exceed $100 per sale.",
    "royaltydue": 3503,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0698,
    "effectiveincometaxratereconciliationtaxcreditsother": 0.0007,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2791,
    "allowancefordoubtfulaccountsreceivable": 7598,
    "stockoptionsissuedforservices": 1632377,
    "deferredtaxassetsoperatinglosscarryforwards": 4766552,
    "deferredtaxassetsother": 19516,
    "deferredtaxassetsgross": 6426043,
    "royaltyobligation": -708046,
    "deferredtaxliabilitiesother": -42915,
    "deferredincometaxliabilities": -750961,
    "deferredtaxassetsnet": 5675082,
    "deferredtaxassetsvaluationallowance": -5675082,
    "federalnetoperatinglossescarryforwardexpiryperiod": 2033,
    "operatinglosscarryforwards": 17000000,
    "cumulativechangeinownership": 0.5,
    "valuationallowancesandreservesadjustments": 1688457
  }
]